| |
| |
|
| Insider
Information: |
Virgin Herbert |
| Relationship: |
EVP, Research & CSO |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,500 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vir Biotechnology, Inc. |
VIR |
EVP, Research & CSO |
2022-08-09 |
262,500 |
2020-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-08-25 |
4 |
OE |
$1.53 |
$4,208 |
D/D |
2,750 |
102,450 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-15 |
4 |
OE |
$1.53 |
$4,208 |
D/D |
2,750 |
110,450 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-15 |
4 |
AS |
$50.00 |
$137,500 |
D/D |
(2,750) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-11-27 |
4 |
AS |
$30.00 |
$87,900 |
D/D |
(2,930) |
23,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-11-27 |
4 |
OE |
$1.53 |
$4,483 |
D/D |
2,930 |
26,630 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-04-16 |
4 |
OE |
$1.53 |
$5,355 |
D/D |
3,500 |
91,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-19 |
4 |
AS |
$38.00 |
$133,384 |
D/D |
(3,510) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-19 |
4 |
OE |
$1.53 |
$5,370 |
D/D |
3,510 |
3,510 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-29 |
4 |
OE |
$1.53 |
$5,370 |
D/D |
3,510 |
27,210 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-29 |
4 |
AS |
$38.00 |
$133,380 |
D/D |
(3,510) |
23,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-24 |
4 |
OE |
$1.53 |
$5,661 |
D/D |
3,700 |
23,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-05-14 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
3,805 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-05-14 |
4 |
AS |
$30.07 |
$114,418 |
D/D |
(3,805) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-05-26 |
4 |
AS |
$34.08 |
$129,674 |
D/D |
(3,805) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-05-26 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
3,805 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-09 |
4 |
AS |
$36.28 |
$138,030 |
D/D |
(3,805) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-09 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
3,805 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-08 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
23,805 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-08 |
4 |
AS |
$29.98 |
$114,098 |
D/D |
(3,805) |
20,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-22 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
23,805 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-09-22 |
4 |
AS |
$31.71 |
$120,638 |
D/D |
(3,805) |
20,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-10-27 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
27,505 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-10-27 |
4 |
AS |
$35.04 |
$133,335 |
D/D |
(3,805) |
23,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-12-08 |
4 |
AS |
$31.27 |
$118,966 |
D/D |
(3,805) |
23,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-12-08 |
4 |
OE |
$1.53 |
$5,822 |
D/D |
3,805 |
27,505 |
0 |
- |
|
123 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
